# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Madam C. J. Walker (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET019-SYN
- Date: 2026-06-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Okonjo-Bell, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Madam Walker is a 49-year-old company founder with hypertension and chronic kidney disease G3a A2 who comes for her yearly preventive visit six weeks after her eleven-week review. Amlodipine was added then, and her home readings now average 127/80. She has had no ankle swelling, dizziness or genital itching. She restarted losartan and empagliflozin after the stomach illness two months ago and has had no further trouble. She has been on the road three weeks out of four, sleeping six hours on travel nights. She is using the salt-free seasoning at home and asking for sauces on the side at banquets. She wants to know which screening tests she needs and when, so that she can fit them between trips. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 49 |
| Home blood pressure | Average 127/80 on losartan 100 mg and amlodipine 5 mg |
| Travel | Three weeks in four |
| Mood | PHQ-2 0 |

## Health risk assessment

Completed on the patient portal before the visit and reviewed with her by Dr. Okonjo-Bell. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Busy and purposeful; stress from the pace of work, which she manages and does not want to give up |
| Substance use | No tobacco or drugs; a glass of wine at some events (AUDIT-C 1) |
| Physical activity | Walks during layovers and on home mornings, about 120 minutes a week |
| Nutrition | Salt-free seasoning at home; sauces on the side and no added salt on the road; water in place of a third coffee |
| Sleep | Six hours on travel nights, seven at home |
| Food and housing | Secure |
| Safety | Seat belt always; feels safe at home |
| Health care experiences | Wants the numbers and the reasons; satisfied that her plan fits her work |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight change; weight down 2.4 kg since intake |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hoarseness |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | Stomach illness resolved; no blood in the stool |
| Genitourinary | Negative | No burning, itching or discharge; periods becoming irregular |
| Breast | Negative | No lump, skin change or nipple discharge |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No changing moles; no scalp or hair problems |
| Neurological | Negative | No headaches since her blood pressure came down |
| Psychiatric | Negative | Mood steady; PHQ-2 0 |

12 systems reviewed. **S**

## Current medications

- Losartan 100 mg oral tablet, one tablet each morning **S**
- Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgery **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**
- Amlodipine 5 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/80 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 76.6 kg; BMI 28.8 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Immunizations given today

- Pneumococcal conjugate vaccine PCV20 **S**
- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 76.6 kg, BMI 28.8; blood pressure 126/80 |
| Eyes | Visual acuity 20/20 in each eye with reading glasses for near |
| Mouth | Teeth and gums healthy |
| Neck | No thyroid enlargement |
| Cardiovascular | Regular rhythm; no murmur; no ankle swelling |
| Respiratory | Clear |
| Breast | Examined with a female chaperone and her agreement: no masses, skin changes or nipple discharge |
| Abdomen | Soft, non-tender |
| Skin | No suspicious lesions |
| Psychiatric | Engaged and direct |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B screening were done with the kidney evaluation in February and were negative, without hepatitis B immunity. She chose a primary HPV test today for cervical screening, a stool immunochemical test kit she can mail from the road, and a mammogram in two weeks on a home day. Pneumococcal, Tdap and the first hepatitis B vaccines given with her agreement. **S**
   - Mammogram in two weeks.
   - Mail the stool test kit.
   - Second hepatitis B dose in about two months, at the six-month review.
   - Recombinant zoster vaccine from 50, after her birthday.
   - Influenza and COVID-19 vaccines in the autumn.
   - Next preventive visit in one year.
2. **Hypertension with chronic kidney disease** (I12.9). At goal at home and in the clinic on losartan 100 mg and amlodipine 5 mg. **S**
   - Continue the current medicines and home readings twice a week, on the road too.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 126/80 mmHg; home average 127/80 |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1 |
| Tobacco use | Completed today | Never |
| Breast cancer screening | Ordered | Mammogram every two years from 40; booked in two weeks on a day she is home |
| Cervical cancer screening | Completed today | Primary HPV test every five years from 30, her choice |
| Colorectal cancer screening | Ordered | From 45; stool immunochemical test yearly, her choice so that she can mail it while traveling; colonoscopy discussed |
| HIV screening | Up to date | Negative with the kidney evaluation in February |
| Hepatitis C screening | Up to date | Negative with the kidney evaluation in February |
| Hepatitis B screening | Up to date | Surface antigen negative, no immunity, in February; vaccination started today |
| Diabetes screening | Up to date | A1c 5.4% at intake |
| Statin for prevention | Up to date | Atorvastatin 20 mg since February; LDL 98 mg/dL |
| Healthy diet and physical activity counseling | Completed today | Sodium plan with the dietitian; walking during layovers |
| Pneumococcal vaccine | Completed today | PCV20 for chronic kidney disease |
| Tdap | Completed today | No booster within ten years |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 (HepB-CpG) |
| Recombinant zoster vaccine | Due | From 50, after her birthday |
| Influenza and COVID-19 vaccines | Due | Influenza given in February; both due in the autumn |
| Eye examination | Due | Mild hypertensive retinopathy at intake; dilated examination by an optometrist yearly |
| Osteoporosis screening | Not indicated | Not yet postmenopausal and no risk factors that call for earlier screening |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any illness that could be reversed, including dialysis if her kidneys ever failed, and wants to be told plainly what is happening at every stage. She has named a health care agent, recorded in the confidential part of the chart and not named here, and has a will and business succession plan in place through her company. She chose not to record other treatment preferences today. To be revisited yearly or after any serious illness. **S**

## Guideline basis

- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Breast Cancer: Screening (2024), U.S. Preventive Services Task Force
- Cervical Cancer: Screening (2018), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023 (2023), Centers for Disease Control and Prevention (MMWR Recomm Rep 2023)

## Follow-up

- Mammogram in two weeks; stool test by mail; HPV result by the portal. Six-month review in ten weeks with urine albumin, kidney function, hemoglobin, the PHQ-9 and the second hepatitis B dose. Next preventive visit in one year. **S**
- Next scheduled visit 2026-08-17: six-month review: blood pressure at goal, urine albumin, kidney function, hemoglobin, mood, and the travel season ahead. **S**
